Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway
Antimicrobial Agents and Chemotherapy · 11.11.2026
DOI: 10.1128/aac.00963-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 11.11.2026. Verfasst von Junbo Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Huaqiao University, Quanzhou, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quanzhou Science and Technology Project, Joint fund project for scientific and technological innovation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Coxsackievirus B3 (CVB3) is the primary pathogen of viral myocarditis (VMC), and there is no specific therapy. Rosmarinic acid (RA) has anti-inflammatory and antioxidant properties, but its anti-CVB3 activity and mechanism remain unclear. This study examined the inhibitory effect of RA on CVB3 replication and VMC, and the underlying mechanism. In CVB3-infected HeLa cells and a mouse VMC model, RA blocked viral replication dose-dependently, with an EC50 of 26.49 μM and a selectivity index of 21.72, which was more effective than ribavirin. Time-of-addition experiments showed that RA interfered with the post-entry replication stage. Mechanistically, RA directly bound sirtuin 1 (SIRT1), with an affinity of −10.2 kcal/mol, increasing its conformational stability and inhibiting ubiquitin-proteasome degradation, thereby reversing CVB3-induced SIRT1 downregulation. Antiviral and anti-inflammatory effects of RA were abolished by SIRT1 knockdown. RA activated the AMPK/Nrf2/HO-1 cascade in a SIRT1-dependent manner. Notably, the HO-1 metabolite biliverdin (BV) stimulated STAT1/2 phosphorylation and interferon-stimulated gene expression. In vivo , RA effectively ameliorated CVB3-induced myocardial injury and restored SIRT1/AMPK/Nrf2/HO-1 expression. In conclusion, RA prevents CVB3 replication and VMC via direct binding and stabilization of SIRT1, activation of the SIRT1/AMPK/Nrf2/HO-1/BV signaling pathway, and stimulation of interferon response through STAT1/2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Huaqiao University, Quanzhou, China.
ORCID-Profile: Junbo Huang, Lei Tong
Förderung
- Quanzhou Science and Technology Project
- Joint fund project for scientific and technological innovation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Huang, J., Song, Q., Di, Y., Cheng, Z., Lin, H., Zhan, H., Chen, Y., Wang, Y., Xie, L., Wang, F., & Tong, L. (2026). Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00963-26
Vancouver
Huang J, Song Q, Di Y, Cheng Z, Lin H, Zhan H, et al. Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00963-26
BibTeX
@article{Huang2026,
author = {Huang, Junbo and Song, Qing and Di, Yanjun and Cheng, Zhiyun and Lin, Haowei and Zhan, Haoyi and Chen, Yanhui and Wang, Yachen and Xie, Lijuan and Wang, Fucai and Tong, Lei},
title = {Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00963-26}
}
EUVIMED